Comparative In-Vitro Aerodynamic Characterization of Marketed Dry Powder Inhalers Using the Aerolizer Type of Device

Formoterol fumarate (FF) and Budesonide combination in a dry powder inhaler dosage form is very commonly prescribed for the treatment of asthma, bronchospasm, chronic bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD). The aerodynamic characteristics and delivered dose of different marketed products are generated during the patient's inhalation and reach the lungs, and give the necessary therapeutic action. To develop a dry powder inhalation product with the consistent delivery of aerodynamic characteristics until the product's shelf life is a challenge for many pharmaceutical companies. The in vitro evaluation is determined by using various techniques, such as Next Generation Impactor (NGI), Glass Twin impinger (GTI), and uniformity of delivered dose (UODD). This study fully compared aerodynamic properties in NGI, GTI, and UODD performance of different marketed products with the Aerolizer type of device. Hence, this technique is preferred by many pharmaceutical companies for the routine quality control testing for dry powder inhaler characterization. It is statutory in a multitude of Pharmacopoeias and adopted by the majority of regulatory bodies across the globe. The main purpose of this study was to evaluate statistically the in vitro evaluation generated using the latest NGI, GTI, and UODD operated at fixed flow rates of 60 L/min. Four marketed products, Foracort 200, Budetrol 200, Combihale FB, and Budamate 200, were chosen for the study and compared with the Aerolizer type of device. The aerodynamic character and delivered dose uniformity. We found a statistically significant difference in the above marketed products available on the Indian market.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11450920/v1
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Comparative In-Vitro Aerodynamic Characterization of Marketed Dry Powder Inhalers Using the Aerolizer Type of Device

Alexandar Sekar, Ravisankar M, Karishma Jeevanandham, Pasupathi Chinnayan et al.
1 links
Research Square
Inhalation and Respiratory Drug Delivery
preprint

Comparative In-Vitro Aerodynamic Characterization of Marketed Dry Powder Inhalers Using the Aerolizer Type of Device

Alexandar Sekar, Ravisankar M, Karishma Jeevanandham, Pasupathi Chinnayan, Nithya Sekar, sangeetha sridharan, Nallakumar Palanisamy
preprint en

Abstract

Formoterol fumarate (FF) and Budesonide combination in a dry powder inhaler dosage form is very commonly prescribed for the treatment of asthma, bronchospasm, chronic bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD). The aerodynamic characteristics and delivered dose of different marketed products are generated during the patient's inhalation and reach the lungs, and give the necessary therapeutic action. To develop a dry powder inhalation product with the consistent delivery of aerodynamic characteristics until the product's shelf life is a challenge for many pharmaceutical companies. The in vitro evaluation is determined by using various techniques, such as Next Generation Impactor (NGI), Glass Twin impinger (GTI), and uniformity of delivered dose (UODD). This study fully compared aerodynamic properties in NGI, GTI, and UODD performance of different marketed products with the Aerolizer type of device. Hence, this technique is preferred by many pharmaceutical companies for the routine quality control testing for dry powder inhaler characterization. It is statutory in a multitude of Pharmacopoeias and adopted by the majority of regulatory bodies across the globe. The main purpose of this study was to evaluate statistically the in vitro evaluation generated using the latest NGI, GTI, and UODD operated at fixed flow rates of 60 L/min. Four marketed products, Foracort 200, Budetrol 200, Combihale FB, and Budamate 200, were chosen for the study and compared with the Aerolizer type of device. The aerodynamic character and delivered dose uniformity. We found a statistically significant difference in the above marketed products available on the Indian market.

Research Square
Vinayaka Missions University (IN), Tamil Nadu Dr. M.G.R. Medical University (IN)
Good health and well-being
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon